FDA Media Alert Detail

Drug Shortage

FDA Drug Shortage: Dexmedetomidine Hydrochloride Injection

  • U.S. Food and Drug Administration
  • August 20, 2026
  • ID: shortage-dexmedetomidine-hydrochloride-injection-mylan-institutional-a-viatris-company-67457-925-10

Drug Shortage Details

Generic NameDexmedetomidine Hydrochloride Injection
Manufacturer / CompanyMylan Institutional, a Viatris Company
Therapeutic CategoryAnesthesia
Availability StatusAvailable
Status (FDA list)Current
NDC Package Code67457-925-10
Presentation & Dosage Form

Dexmedetomidine Hydrochloride, Injection, 400 ug/100 mL (NDC 67457-925-10)

Manufacturer Contact Info

800-796-9526

Content syndicated from the U.S. Food and Drug Administration (FDA) Drug Shortages Database.
View Official Announcement on FDA.gov

Recent FDA Updates

FDA Safety Alert
BMC Medical Co., Ltd. Recalls Luna G3 APAP (Model LG3600) wi...
Sep 8, 2026
FDA Safety Alert
Early Alert: Breathing Circuit Issue from Draeger
Sep 3, 2026
FDA Safety Alert
Monitoring System Correction: GE HealthCare Updates Use Inst...
Sep 3, 2026
Back to FDA Media Center